Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker COLL
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Dreyer Scott Former Officer | COLL Collegium Pharmaceutical, Inc. | 27,419 | $603.3K | — | Sep 30, 2026 | — | Form 144 ↗ |
| Jul 17, 2026 | John A. Fallon Former Director | COLL Collegium Pharmaceutical, Inc. | 13,920 | $497.4K | — | Jul 17, 2026 | — | Form 144 ↗ |
| Jul 15, 2026 | John A. Fallon Former Director | COLL Collegium Pharmaceutical, Inc. | 8,095 | $294.0K | — | Jul 15, 2026 | — | Form 144 ↗ |
| May 18, 2026 | Freund John Gordon Director | COLL Collegium Pharmaceutical, Inc. | 30 | $1,022 | — | May 18, 2026 | Form 4 ↗ 2 days later · 20 shares | Form 144 ↗ |
| May 15, 2026 | Freund John Gordon Director | COLL Collegium Pharmaceutical, Inc. | 4,127 | $142.5K | — | May 15, 2026 | Form 4 ↗ 3 days later · 4,127 shares | Form 144 ↗ |
| May 13, 2026 | Nancy Lurker Director | COLL Collegium Pharmaceutical, Inc. | 4,500 | $161.9K | — | May 13, 2026 | Form 4 ↗ 2 days later · 4,500 shares | Form 144 ↗ |
| May 11, 2026 | Garen G. Bohlin Director | COLL Collegium Pharmaceutical, Inc. | 8,700 | $323.5K | — | May 11, 2026 | Form 4 ↗ 2 days later · 8,700 shares | Form 144 ↗ |
| Mar 18, 2026 | David Dieter Officer | COLL Collegium Pharmaceutical, Inc. | 13,976 | $488.1K | 10b5-1 | Mar 18, 2026 | Form 4 ↗ 2 days later · 13,976 shares | Form 144 ↗ |
| Mar 9, 2026 | David Dieter Officer | COLL Collegium Pharmaceutical, Inc. | 6,224 | $228.1K | 10b5-1 | Mar 9, 2026 | Form 4 ↗ 2 days later · 6,224 shares | Form 144 ↗ |
| Mar 3, 2026 | Dreyer Scott Officer | COLL Collegium Pharmaceutical, Inc. | 49,976 | $2.0M | 10b5-1 | Mar 3, 2026 | Form 4 ↗ 2 days later · 49,976 shares | Form 144 ↗ |
| Dec 17, 2025 | Rita Balice-Gordon DIRECTOR | COLL Collegium Pharmaceutical, Inc. | 3,650 | $171.7K | — | Dec 5, 2025 | — | Form 144 ↗ |
| Dec 8, 2025 | Dreyer Scott Officer | COLL Collegium Pharmaceutical, Inc. | 17,600 | $847.9K | 10b5-1 | Dec 8, 2025 | Form 4 ↗ 2 days later · 17,600 shares | Form 144 ↗ |
| Nov 12, 2025 | John A. Fallon Director | COLL Collegium Pharmaceutical, Inc. | 34,853 | $1.6M | — | Nov 12, 2025 | Form 4 ↗ 2 days later · 34,853 shares | Form 144 ↗ |
| Nov 6, 2025 | Colleen Tupper Officer | COLL Collegium Pharmaceutical, Inc. | 30,000 | $1.2M | 10b5-1 | Nov 6, 2025 | Form 4 ↗ 1 day later · 30,000 shares | Form 144 ↗ |
| Aug 29, 2025 | Thomas B. Smith Officer | COLL Collegium Pharmaceutical, Inc. | 17,478 | $671.6K | — | Aug 29, 2025 | Form 4 ↗ 5 days later · 17,478 shares | Form 144 ↗ |
| Aug 18, 2025 | Dreyer Scott Officer | COLL Collegium Pharmaceutical, Inc. | 16,389 | $626.2K | 10b5-1 | Aug 18, 2025 | Form 4 ↗ 2 days later · 16,389 shares | Form 144 ↗ |
| Aug 15, 2025 | Santini Gino Director | COLL Collegium Pharmaceutical, Inc. | 5,405 | $201.0K | — | Aug 15, 2025 | Form 4 ↗ 4 days later · 5,405 shares | Form 144 ↗ |
| Aug 13, 2025 | Dreyer Scott Officer | COLL Collegium Pharmaceutical, Inc. | 4,861 | $184.9K | 10b5-1 | Aug 13, 2025 | Form 4 ↗ 2 days later · 4,861 shares | Form 144 ↗ |
| Jul 9, 2025 | Heffernan Michael Thomas Former Director | COLL Collegium Pharmaceutical, Inc. | 10,328 | $332.3K | — | Jul 9, 2025 | — | Form 144 ↗ |
| Jul 8, 2025 | Heffernan Michael Thomas Former Director | COLL Collegium Pharmaceutical, Inc. | 790 | $24.8K | — | Jul 8, 2025 | — | Form 144 ↗ |
| Jul 7, 2025 | Heffernan Michael Thomas Former Director | COLL Collegium Pharmaceutical, Inc. | 14,210 | $444.1K | — | Jul 7, 2025 | — | Form 144 ↗ |
| Jul 2, 2025 | Heffernan Michael Thomas Former Director | COLL Collegium Pharmaceutical, Inc. | 25,000 | $757.4K | — | Jul 2, 2025 | — | Form 144 ↗ |
| Jul 2, 2025 | Gwen A. Melincoff Former Director | COLL Collegium Pharmaceutical, Inc. | 47,082 | $1.4M | — | Jul 2, 2025 | — | Form 144 ↗ |
| Jun 9, 2025 | Freund John Gordon Director | COLL Collegium Pharmaceutical, Inc. | 6,601 | $202.1K | — | Jun 9, 2025 | Form 4 ↗ 2 days later · 6,601 shares | Form 144 ↗ |
| Mar 21, 2025 | Colleen Tupper Officer | COLL Collegium Pharmaceutical, Inc. | 6,396 | $192.1K | 10b5-1 | Mar 21, 2025 | Form 4 ↗ 3 days later · 7,602 shares | Form 144 ↗ |
| Mar 21, 2025 | Dreyer Scott Officer | COLL Collegium Pharmaceutical, Inc. | 18,881 | $567.0K | 10b5-1 | Mar 21, 2025 | Form 4 ↗ 3 days later · 20,808 shares | Form 144 ↗ |
| Mar 20, 2025 | Colleen Tupper Officer | COLL Collegium Pharmaceutical, Inc. | 1,206 | $36.2K | 10b5-1 | Mar 20, 2025 | Form 4 ↗ 4 days later · 7,602 shares | Form 144 ↗ |
| Mar 20, 2025 | Shirley R. Kuhlmann Former Officer | COLL Collegium Pharmaceutical, Inc. | 40,494 | $1.2M | — | Mar 20, 2025 | — | Form 144 ↗ |
| Mar 20, 2025 | Dreyer Scott Officer | COLL Collegium Pharmaceutical, Inc. | 1,927 | $57.8K | 10b5-1 | Mar 20, 2025 | Form 4 ↗ 4 days later · 20,808 shares | Form 144 ↗ |
| Mar 14, 2025 | Colleen Tupper Officer | COLL Collegium Pharmaceutical, Inc. | 977 | $29.3K | 10b5-1 | Mar 14, 2025 | Form 4 ↗ 4 days later · 977 shares | Form 144 ↗ |
| Mar 14, 2025 | Dreyer Scott Officer | COLL Collegium Pharmaceutical, Inc. | 2,255 | $67.7K | 10b5-1 | Mar 14, 2025 | Form 4 ↗ 4 days later · 2,255 shares | Form 144 ↗ |
| Mar 11, 2025 | Colleen Tupper Officer | COLL Collegium Pharmaceutical, Inc. | 10,445 | $313.4K | 10b5-1 | Mar 11, 2025 | Form 4 ↗ 2 days later · 10,445 shares | Form 144 ↗ |
| Mar 11, 2025 | Dreyer Scott Officer | COLL Collegium Pharmaceutical, Inc. | 15,387 | $461.7K | 10b5-1 | Mar 11, 2025 | Form 4 ↗ 7 days later · 2,255 shares | Form 144 ↗ |
| Mar 7, 2025 | Dreyer Scott Officer | COLL Collegium Pharmaceutical, Inc. | 2,348 | $70.4K | 10b5-1 | Mar 7, 2025 | Form 4 ↗ 3 days later · 5,643 shares | Form 144 ↗ |
| Mar 7, 2025 | Colleen Tupper Officer | COLL Collegium Pharmaceutical, Inc. | 1,504 | $45.1K | 10b5-1 | Mar 7, 2025 | Form 4 ↗ 3 days later · 3,453 shares | Form 144 ↗ |
| Mar 6, 2025 | Colleen Tupper Officer | COLL Collegium Pharmaceutical, Inc. | 1,949 | $58.5K | 10b5-1 | Mar 6, 2025 | Form 4 ↗ 4 days later · 3,453 shares | Form 144 ↗ |
| Mar 6, 2025 | Dreyer Scott Officer | COLL Collegium Pharmaceutical, Inc. | 3,295 | $98.9K | 10b5-1 | Mar 6, 2025 | Form 4 ↗ 4 days later · 5,643 shares | Form 144 ↗ |
| Mar 6, 2025 | Shirley R. Kuhlmann Officer | COLL Collegium Pharmaceutical, Inc. | 26,067 | $742.9K | — | Mar 6, 2025 | Form 4 ↗ same day · 86,067 shares | Form 144 ↗ |
| Mar 5, 2025 | Shirley R. Kuhlmann Officer | COLL Collegium Pharmaceutical, Inc. | 20,000 | $560.5K | — | Mar 5, 2025 | Form 4 ↗ 1 day later · 86,067 shares | Form 144 ↗ |
| Mar 4, 2025 | Shirley R. Kuhlmann Officer | COLL Collegium Pharmaceutical, Inc. | 40,000 | $1.1M | — | Mar 4, 2025 | Form 4 ↗ 2 days later · 86,067 shares | Form 144 ↗ |
| Jan 10, 2025 | Shirley R. Kuhlmann Officer | COLL Collegium Pharmaceutical, Inc. | 27,500 | $908.6K | 10b5-1 | Jan 10, 2025 | Form 4 ↗ 4 days later · 27,500 shares | Form 144 ↗ |
| Sep 13, 2024 | Thomas B. Smith Officer | COLL Collegium Pharmaceutical, Inc. | 9,220 | $337.5K | — | Sep 13, 2024 | — | Form 144 ↗ |
| Sep 13, 2024 | Thomas B. Smith Officer | COLL Collegium Pharmaceutical, Inc. | 373 | $13.8K | — | Sep 13, 2024 | — | Form 144 ↗ |
| Sep 6, 2024 | Shirley R. Kuhlmann Officer | COLL Collegium Pharmaceutical, Inc. | 977 | $36.6K | — | Sep 6, 2024 | — | Form 144 ↗ |
| Sep 5, 2024 | Shirley R. Kuhlmann Officer | COLL Collegium Pharmaceutical, Inc. | 19,248 | $737.2K | — | Sep 5, 2024 | — | Form 144 ↗ |
| Aug 12, 2024 | Neil F. McFarlane Former Director | COLL Collegium Pharmaceutical, Inc. | 44,365 | $1.6M | — | Aug 12, 2024 | — | Form 144 ↗ |
| Aug 9, 2024 | Neil F. McFarlane Former Director | COLL Collegium Pharmaceutical, Inc. | 5,000 | $176.0K | — | Aug 9, 2024 | — | Form 144 ↗ |
| Jun 5, 2024 | Joseph Ciaffoni Former Officer & Director | COLL Collegium Pharmaceutical, Inc. | 131,196 | $4.2M | — | Jun 5, 2024 | — | Form 144 ↗ |
| Jun 4, 2024 | Joseph Ciaffoni Former Officer & Director | COLL Collegium Pharmaceutical, Inc. | 84,313 | $2.7M | — | Jun 4, 2024 | — | Form 144 ↗ |
| Jun 3, 2024 | Joseph Ciaffoni Former Officer & Director | COLL Collegium Pharmaceutical, Inc. | 52,572 | $1.7M | — | Jun 3, 2024 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:28 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances